{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:57:44Z","timestamp":1790740664480,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","funder":[{"name":"SystemsX.ch, Switzerland","award":["2014"],"award-info":[{"award-number":["2014"]}]},{"name":"SystemsX.ch, Switzerland","award":["2015"],"award-info":[{"award-number":["2015"]}]},{"name":"SwissTransMed, Switzerland","award":["2014"],"award-info":[{"award-number":["2014"]}]},{"name":"\u00d6rebro County Council Research Committee, Sweden","award":["2013"],"award-info":[{"award-number":["2013"]}]},{"DOI":"10.13039\/501100006736","name":"Universitetssjukhuset \u00d6rebro","doi-asserted-by":"publisher","award":["2013"],"award-info":[{"award-number":["2013"]}],"id":[{"id":"10.13039\/501100006736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01377","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T01:21:42Z","timestamp":1449710502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae"],"prefix":"10.3389","volume":"6","author":[{"given":"Sunniva","family":"Foerster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy J.","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Althaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1128\/AAC.04456-14","article-title":"Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae.","volume":"59","author":"Alm","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jiac.2015.02.001","article-title":"Applications of the pharmacokinetic\/pharmacodynamic (PK\/PD) analysis of antimicrobial agents.","volume":"21","author":"As\u00edn-Prieto","year":"2015","journal-title":"J. Infect. Chemother."},{"issue":"11827","key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/srep11827","article-title":"Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.","volume":"5","author":"Basarab","year":"2015","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.5772\/30922","article-title":"\u201cDrug synergy \u2013 mechanisms and methods of analysis,\u201d in","author":"Breitinger","year":"2012","journal-title":"Toxicity and Drug Testing,"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.","volume":"67","author":"C\u00e1mara","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B6","first-page":"1","article-title":"Cephalosporin-Resistant Neisseria gonorrhoeae Public Health Response Plan.","author":"Centers for Disease Control and Prevention [CDC]","year":"2012"},{"key":"B7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0167-7012(03)00194-5","article-title":"A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli.","volume":"55","author":"Chen","year":"2003","journal-title":"J. Microbiol. Methods"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.","volume":"68","author":"Chen","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B10","article-title":"Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement. CLSI Document M100-S24.","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"B11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u201cbug and drug.\u201d","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/028506","article-title":"Time-kill curve analysis and pharmacodynamic functions for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.","author":"Foerster","year":"2015","journal-title":"bioRxiv"},{"issue":"20862","key":"B13","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.30.20862","article-title":"Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.","volume":"19","author":"Golparian","year":"2014a","journal-title":"Euro Surveill."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/AAC.00038-14","article-title":"Importance of multi-drug e\ufb04ux pumps in the antimicrobial resistance property of clinical multi-drug resistant isolates of Neisseria gonorrhoeae.","volume":"58","author":"Golparian","year":"2014b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","first-page":"509","article-title":"Use of a non-selective transformation technique to construct a multiply restriction\/modification-deficient mutant of Neisseria gonorrhoeae.","volume":"251","author":"Gunn","year":"1996","journal-title":"Mol. Gen. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/AAC.04124-14","article-title":"In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase\/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.","volume":"59","author":"Huband","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QCO.0b013e32834e9a6a","article-title":"Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment.","volume":"25","author":"Ison","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.","volume":"7","author":"Jacobs","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1128\/AAC.03090-14","article-title":"High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.","volume":"58","author":"Jacobsson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"20984","DOI":"10.1074\/jbc.M115.663534","article-title":"Inhibition of Neisseria gonorrhoeae type II topoisomerases by the novel spiropyrimidinetrione AZD0914.","volume":"290","author":"Kern","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199937010-00001","article-title":"Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.","volume":"37","author":"Li","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/cr4003984","article-title":"Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.","volume":"114","author":"Mayer","year":"2014","journal-title":"Chem. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/AAC.00999-09","article-title":"Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them.","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","article-title":"\u201cAZD0914: a Neisseria gonorrhoeae Topoisomerase II inhibitor with novel mode of inhibition, poster C-1422\u201d in","author":"Palmer","year":"2014","journal-title":"Proceedings of the Abstracts 54th Interscience Conference Antimicrobial Agents Chemotherapy American Society for Microbiology,"},{"key":"B27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1071\/SH13077","article-title":"One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia.","volume":"10","author":"Read","year":"2013","journal-title":"Sex Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","article-title":"Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.","volume":"48","author":"Regoes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","author":"Ritz","year":"2005","journal-title":"Bioassay Analysis Using R. J. Stat. Softw. 12."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes.","volume":"63","author":"Unemo","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"19792","key":"B31","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012a","journal-title":"Antimicrob. Agents Chemother."},{"issue":"20200","key":"B33","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.","volume":"17","author":"Unemo","year":"2012b","journal-title":"Euro Surveill."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1574-6968.2007.00776.x","article-title":"A fully defined, clear and protein-free liquid medium permitting dense growth of Neisseria gonorrhoeae from very low inocula.","volume":"273","author":"Wade","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"B37","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","author":"World Health Organization and Department of Reproductive Health and Research","year":"2012a","journal-title":"Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae."},{"key":"B39","author":"World Health Organization and Department of Reproductive Health and Research","year":"2012b","journal-title":"Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections \u2013 2008."},{"key":"B40","author":"World Health Organization [WHO]","year":"2008","journal-title":"Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections - 2008."},{"issue":"e986048","key":"B41","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/986048","article-title":"Advanced heat map and clustering analysis using Heatmap3.","volume":"2014","author":"Zhao","year":"2014","journal-title":"BioMed. Res. Int."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T05:25:03Z","timestamp":1567401903000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01377\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":41,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01377","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]}}}